Hmdb loader
Record Information
Version5.0
StatusPredicted
Creation Date2021-09-13 03:11:49 UTC
Update Date2022-11-30 20:00:11 UTC
HMDB IDHMDB0275252
Secondary Accession NumbersNone
Metabolite Identification
Common NamePGP(i-16:0/18:2(9Z,11E)+=O(13))
DescriptionPGP(i-16:0/18:2(9Z,11E)+=O(13)) is an oxidized phosphoglycerophosphate (PGP). Oxidized phosphoglycerophosphates are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphoglycerophosphates belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396 ). As is the case with diacylglycerols, phosphoglycerophosphates can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PGP(i-16:0/18:2(9Z,11E)+=O(13)), in particular, consists of one chain of one 14-methylpentadecanoyl at the C-1 position and one chain of 13-oxo-octadecadienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGPs can be synthesized via three different routes. In one route, the oxidized PGP is synthetized de novo following the same mechanisms as for PGPs but incorporating oxidized acyl chains (PMID: 33329396 ). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396 ). The third pathway results from the oxidation of the acyl chain while still attached to the PGP backbone, mainely through the action of LOX (PMID: 33329396 ).
Structure
Thumb
Synonyms
ValueSource
[(2S)-2-Hydroxy-3-({hydroxy[(2R)-3-[(14-methylpentadecanoyl)oxy]-2-{[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonateGenerator
Chemical FormulaC40H74O14P2
Average Molecular Weight840.966
Monoisotopic Molecular Weight840.455381059
IUPAC Name[(2S)-2-hydroxy-3-({hydroxy[(2R)-3-[(14-methylpentadecanoyl)oxy]-2-{[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxy}propoxy]phosphoryl}oxy)propoxy]phosphonic acid
Traditional Name(2S)-2-hydroxy-3-{[hydroxy((2R)-3-[(14-methylpentadecanoyl)oxy]-2-{[(9Z,11E)-13-oxooctadeca-9,11-dienoyl]oxy}propoxy)phosphoryl]oxy}propoxyphosphonic acid
CAS Registry NumberNot Available
SMILES
[H][C@](O)(COP(O)(O)=O)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC\C=C/C=C/C(=O)CCCCC
InChI Identifier
InChI=1S/C40H74O14P2/c1-4-5-21-27-36(41)28-23-18-14-10-8-12-16-20-25-30-40(44)54-38(34-53-56(48,49)52-32-37(42)31-51-55(45,46)47)33-50-39(43)29-24-19-15-11-7-6-9-13-17-22-26-35(2)3/h14,18,23,28,35,37-38,42H,4-13,15-17,19-22,24-27,29-34H2,1-3H3,(H,48,49)(H2,45,46,47)/b18-14-,28-23+/t37-,38+/m0/s1
InChI KeyBSRRYGPXOHAHHJ-WXDFCBGXSA-N
Chemical Taxonomy
ClassificationNot classified
Ontology
Physiological effectNot Available
DispositionNot Available
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP6.18ALOGPS
logP10ChemAxon
logS-6ALOGPS
pKa (Strongest Acidic)1.35ChemAxon
pKa (Strongest Basic)-3.4ChemAxon
Physiological Charge-3ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area212.42 ŲChemAxon
Rotatable Bond Count41ChemAxon
Refractivity218.18 m³·mol⁻¹ChemAxon
Polarizability95.52 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
AllCCS[M+H]+291.5632859911
AllCCS[M+H-H2O]+291.61132859911
AllCCS[M+Na]+291.44732859911
AllCCS[M+NH4]+291.47732859911
AllCCS[M-H]-285.58232859911
AllCCS[M+Na-2H]-292.27732859911
AllCCS[M+HCOO]-299.63932859911
DeepCCS[M+H]+288.18930932474
DeepCCS[M-H]-286.10430932474
DeepCCS[M-2H]-319.34430932474
DeepCCS[M+Na]+294.10330932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PGP(i-16:0/18:2(9Z,11E)+=O(13))[H][C@](O)(COP(O)(O)=O)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC\C=C/C=C/C(=O)CCCCC5597.1Standard polar33892256
PGP(i-16:0/18:2(9Z,11E)+=O(13))[H][C@](O)(COP(O)(O)=O)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC\C=C/C=C/C(=O)CCCCC4773.4Standard non polar33892256
PGP(i-16:0/18:2(9Z,11E)+=O(13))[H][C@](O)(COP(O)(O)=O)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC\C=C/C=C/C(=O)CCCCC5782.0Semi standard non polar33892256
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 10V, Positive-QTOFsplash10-0006-5100060790-7ccefdabf148379720802021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 20V, Positive-QTOFsplash10-0553-3300039600-78477db4f25910d9ea142021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 40V, Positive-QTOFsplash10-0udi-5391222000-48ce829033a4182f62802021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 10V, Negative-QTOFsplash10-000i-0010000090-54694acea3a8401056a72021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 20V, Negative-QTOFsplash10-0f7a-2090030030-c643eaaf9575891df0032021-10-19Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - PGP(i-16:0/18:2(9Z,11E)+=O(13)) 40V, Negative-QTOFsplash10-0f95-3091030000-e99aeef1faa34ed5a3452021-10-19Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB: The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne). 2020 Nov 19;11:591819. doi: 10.3389/fendo.2020.591819. eCollection 2020. [PubMed:33329396 ]